ZZUNEUi020-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	ZZUNEUi020-A
Cite as:	ZZUNEUi020-A (RRID:CVCL_A4UN)
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	7th December 2020
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
External Databases
Cellosaurus	CVCL_A4UN
Wikidata	Q107117588
General Information
Publications	Jiang X et al. Uncovering Inherited Cardiomyopathy With Human Induced Pluripotent Stem Cells. Frontiers in cell and developmental biology. 2021;9:672039. Li X et al. A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy. Stem cell research. 2021 Mar;51:102158. Hong J et al. Generation of a human iPSC line ZZUNEUi014-A from a patient with antithrombin deficiency caused by mutation in SERPINC1 gene. Stem cell research. 2022 Mar;59:102646. Sugie K. Editorial commentary: Highlighting the ray of hope in Danon disease research after 40 years. Trends in cardiovascular medicine. 2023 Feb;33(2):90-91. Zhai Y et al. Clinical features of Danon disease and insights gained from LAMP-2 deficiency models. Trends in cardiovascular medicine. 2023 Feb;33(2):81-89. Gao Yuan et al. MYH7 in cardiomyopathy and skeletal muscle myopathy. Molecular and Cellular Biochemistry. 2024-02-00. Sugie Kazuma et al. History and Perspective of LAMP-2 Deficiency (Danon Disease). Biomolecules. 2024-10-09. Wang Brian Xiangzhi. Investigating Inherited Heart Diseases Using Human Induced Pluripotent Stem Cell-Based Models. Life. 2024-10-25.

hIPSC Derivation

General